scholarly journals The Advantages and Disadvantages of Prokinetics

2021 ◽  
Vol 96 (6) ◽  
pp. 478-483
Author(s):  
Jeongkuk Seo ◽  
Kee Wook Jung
Keyword(s):  
Gastrointestinal Tract ◽  
Side Effects ◽  
Gastrointestinal Motility ◽  
Receptor Agonist ◽  
Serotonin Receptor ◽  
Human Gastrointestinal Tract ◽  
Cardiac Side Effects ◽  
Gastrointestinal Dysmotility ◽  
Advantages And Disadvantages ◽  
Selective Agents

Prokinetics are medications that enhance gastrointestinal contractility; they improve the symptoms of patients with delayed gastrointestinal motility. Prokinetics have conventionally been used to stimulate gastrointestinal propulsion and to treat symptoms correlated with motility problems, including gastroparesis and constipation. 5-Hydroxytryptamine receptor 4 (5-HT4) agonists, such as cisapride, very effectively increased human gastrointestinal tract motility. However, cisapride sometimes induced serious tachyarrhythmia; the drug was thus withdrawn from the market. Thereafter, many prokinetics have been developed to treat delayed gastrointestinal motility. However, some exhibit serious side-effects. Recently, a new, highly selective serotonin receptor agonist, prucalopride, has been introduced; there is as yet no evidence of serious cardiac side- effects. The drug has been approved by the Food and Drug Administration to treat chronic constipation. Thus, recently introduced, highly selective agents appear to show promise as treatments for gastrointestinal dysmotility; there seem to be no serious side-effects.

The Design of a Hydraulic Suction Tube for Peroral Biopsy of the Human Gastrointestinal Tract

1962 ◽  
Vol 42 (3) ◽  
pp. 281-284 ◽  
Author(s):  
Wayne E. Quinton ◽  
Arnold L. Flick ◽  
Cyrus E. Rubin
Keyword(s):  
Gastrointestinal Tract ◽  
Human Gastrointestinal Tract ◽  
Suction Tube

The Host Genotype Affects the Bacterial Community in the Human Gastrointestinal Tract

2001 ◽  
Vol 13 (3) ◽  
Author(s):  
Erwin G. Zoetendal ◽  
Antoon D. L. Akkermans ◽  
Wilma M. Akkermans-van Vliet ◽  
J. Arjan G. M. De Visser ◽  
Willem M. De Vos
Keyword(s):  
Gastrointestinal Tract ◽  
Bacterial Community ◽  
Human Gastrointestinal Tract ◽  
Host Genotype

A Review of Drug Side Effect Identification Methods

2020 ◽  
Vol 26 (26) ◽  
pp. 3096-3104 ◽  
Author(s):  
Shuai Deng ◽  
Yige Sun ◽  
Tianyi Zhao ◽  
Yang Hu ◽  
Tianyi Zang
Keyword(s):  
Side Effects ◽  
Future Research ◽  
Drug Side Effects ◽  
Important Indicator ◽  
Advantages And Disadvantages ◽  
Key Points ◽  
Network Methods ◽  
Future Research Directions ◽  
The One ◽  
Approved Drugs

Drug side effects have become an important indicator for evaluating the safety of drugs. There are two main factors in the frequent occurrence of drug safety problems; on the one hand, the clinical understanding of drug side effects is insufficient, leading to frequent adverse drug reactions, while on the other hand, due to the long-term period and complexity of clinical trials, side effects of approved drugs on the market cannot be reported in a timely manner. Therefore, many researchers have focused on developing methods to identify drug side effects. In this review, we summarize the methods of identifying drug side effects and common databases in this field. We classified methods of identifying side effects into four categories: biological experimental, machine learning, text mining and network methods. We point out the key points of each kind of method. In addition, we also explain the advantages and disadvantages of each method. Finally, we propose future research directions.

Chemistry, Analysis, Pharmacokinetics and Pharmacodynamics Aspects of Lorcaserin, a Selective Serotonin 5-HT2C Receptor Agonist: An Update

2020 ◽  
Vol 20 (9) ◽  
pp. 768-778
Author(s):  
Sanjay Sharma ◽  
Komal S. Aware ◽  
Ketan Hatware ◽  
Kiran Patil
Keyword(s):  
Side Effects ◽  
Receptor Agonist ◽  
Scale Up ◽  
Mass Spectrometric ◽  
Selective Serotonin ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Step Method ◽  
Comprehensive Information ◽  
Tissue Matrix ◽  
Liquid Chromatographic

This review refers to the all-inclusive details of Lorcaserin Hydrochloride on comprehensive information about the synthesis, analytical methods, pharmacodynamics, pharmacokinetics, drug interactions and adverse effects. Lorcaserin Hydrochloride is chemically (R)-8-Chloro-1-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine hydrochloride. Lorcaserin HCl is a novel, synthetic, centrally-acting selective serotonin C (5-HT2c) receptor, l agonist, which results in increased satiety and decreased food consumption in patients. Headache, dizziness and nausea are the most common side effects associated with this drug. Lorcaserin HCl has two major metabolites, one conjugated with glucuronide called N-carbamoyl glucuronide which is excreted in urine and the second Lorcaserin N-sulfamate, which is circulated in the blood. Lorcaserin HCl is synthesized using four different schemes of which a six-step method that resulted in 92.3% yield with 99.8% of purity is employed for scale-up production. It is analyzed quantitatively in the plasma and brain tissue matrix of rats by Ultra Performance Liquid chromatographic (UPLC) method using MS-MS (Mass Spectrometric) detection.

Food-grade titanium dioxide particles decrease the bioaccessibility of iron released from spinach leaves in simulated human gastrointestinal tract

2021 ◽  
Author(s):  
Chunyang Li ◽  
Chuanxin Ma ◽  
Heping Shang ◽  
Jason C. White ◽  
David Julian McClements ◽  
...  
Keyword(s):  
Titanium Dioxide ◽  
Gastrointestinal Tract ◽  
Amylase Activity ◽  
Human Gastrointestinal Tract ◽  
Food Grade ◽  
Spinach Leaves

E171 reduced Fe bioaccessibility of spinach in a simulated gastrointestinal tract via two mechanisms: the inhibition of α-amylase activity and adsorption of released Fe from spinach.

scholarly journals Cardiooncology—dealing with modern drug treatment, long-term complications, and cancer survivorship

2021 ◽  
Author(s):  
Claudia de Wall ◽  
Johann Bauersachs ◽  
Dominik Berliner
Keyword(s):  
Side Effects ◽  
Checkpoint Inhibitors ◽  
Heart Diseases ◽  
Tumor Therapy ◽  
Treatment Strategies ◽  
Tumor Treatment ◽  
Cardiac Side Effects ◽  
Cardiovascular Side Effects ◽  
Modern Drug

AbstractModern treatment strategies have improved prognosis and survival of patients with malignant diseases. The key components of tumor treatment are conventional chemotherapy, radiotherapy, targeted therapies, and immunotherapy. Cardiovascular side-effects may occur in the early phase of tumor therapy or even decades later. Therefore, knowledge and awareness of acute and long-lasting cardiac side effects of anti-cancer therapies are essential. Cardiotoxicity impairs quality of life and overall survival. The new cardiologic subspecialty ‘cardio-oncology’ deals with the different cardiovascular problems arising from tumor treatment and the relationship between cancer and heart diseases. Early detection and treatment of cardiotoxicity is of crucial importance. A detailed cardiac assessment of patients prior to administration of cardiotoxic agents, during and after treatment should be performed in all patients. The current review focusses on acute and long-term cardiotoxic side effects of classical cytotoxic and selected modern drug treatments such as immune checkpoint inhibitors and discusses strategies for the diagnosis of treatment-related adverse cardiovascular effects in cancer patients.

Sign in / Sign up

Export Citation Format

Share Document